CDA-2, a urinary preparation, inhibits lung cancer development through the suppression of NF-kappaB activation in myeloid cell.

CDA-2, a urinary preparation, inhibits lung cancer development through the suppression of NF-kappaB activation in myeloid cell.

CDA-2 (cell differentiation agent 2), a urinary preparation, has potent anti- proliferative and pro-apoptotic properties in cancer cells. However, the mechanisms of tumor inhibitory action of CDA-2 are far from clear, and especially there was no report on lung cancer. Here we demonstrate that CDA-2...

Full description

Bibliographic Details
Main Authors: Xuan Wang, Cui-Min Jiang, Hai-Ying Wan, Jun-Lu Wu, Wen-Qiang Quan, Robert Bals, Kai-Yin Wu, Dong Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3524164?pdf=render

Internet

http://europepmc.org/articles/PMC3524164?pdf=render

Similar Items